Literature DB >> 18787377

Salt-wasting congenital adrenal hyperplasia: genotypical peculiarities in a Sicilian ethnic group.

M Wasniewska1, M Caruso, S Indovina, G Crisafulli, S Mirabelli, G Salzano, T Arrigo, F De Luca.   

Abstract

Here we report for the first time the results of the molecular study of 17 unrelated patients with salt-wasting (SW) congenital adrenal hyperplasia (CAH) belonging to a Sicilian ethnic group, as corroborated by patients' pedigree taken to include 2 generations in the paternal and maternal lineage. The aim of this report was to confirm that genetic basis of CAH may be characterized by population differences. In our series, the overall predominant mutation was IVS2A/C>G, that was detected in 50% of alleles and in 58.8% of patients. The allelic and homozygous frequencies of IVS2A/C>G, Del8bpE3, and R356W mutations were significantly higher in our series than in other populations. Our study population included 2 cases with 2 different mutations that have been recently reported for the first time, 3 cases with a double mutation on the same allele, and 1 case with homozygous de novo mutation. We concluded that: a) in a Sicilian ethnic group the most frequent genotype in SW CAH is IVS2A/C>G homozygocity; b) surprisingly Del8bpE3 and R256W homozygocity are also well represented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787377     DOI: 10.1007/BF03345610

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Novel nonsense mutation (W22X) in CYP21A2 gene causing salt-wasting congenital adrenal hyperplasia in a compound heterozygous girl.

Authors:  L Di Pasquale; S Indovina; M Wasniewska; S Mirabelli; P Porcelli; I Rulli; G Salzano; F De Luca
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

2.  Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Robert C Wilson; Saroj Nimkarn; Miro Dumic; Jihad Obeid; Maryam Razzaghy Azar; Maryam Azar; Hossein Najmabadi; Fatemeh Saffari; Maria I New
Journal:  Mol Genet Metab       Date:  2007-02-01       Impact factor: 4.797

3.  Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.

Authors:  V Dolzan; J Sólyom; G Fekete; J Kovács; V Rakosnikova; F Votava; J Lebl; Z Pribilincova; S M Baumgartner-Parzer; S Riedl; F Waldhauser; H Frisch; M Stopar-Obreza; C Krzisnik; T Battelino
Journal:  Eur J Endocrinol       Date:  2005-07       Impact factor: 6.664

4.  Divergent phenotype of two siblings human leukocyte antigen identical, affected by nonclassical and classical congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.

Authors:  O Porzio; V Cunsolo; M Malaponti; E De Nisco; A Acquafredda; L Cavallo; M Andreani; E Giardina; M Testi; M Cappa; G Federici
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

5.  21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.

Authors:  Anca Grigorescu Sido; Matthias M Weber; Paula Grigorescu Sido; Susanne Clausmeyer; Udo Heinrich; Egbert Schulze
Journal:  J Clin Endocrinol Metab       Date:  2005-07-26       Impact factor: 5.958

6.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.

Authors:  Nike M M L Stikkelbroeck; Lies H Hoefsloot; Ilse J de Wijs; Barto J Otten; Ad R M M Hermus; Erik A Sistermans
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

8.  Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.

Authors:  Maher Kharrat; Véronique Tardy; Ridha M'Rad; Faouzi Maazoul; Lamia Ben Jemaa; Mohamed Refaï; Yves Morel; Habiba Chaabouni
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

9.  Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.

Authors:  M Barbaro; S Lajic; L Baldazzi; A Balsamo; P Pirazzoli; A Cicognani; A Wedell; E Cacciari
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

10.  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.

Authors:  R C Wilson; A B Mercado; K C Cheng; M I New
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

View more
  1 in total

1.  A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.

Authors:  M Niceta; M Bono; C Fabiano; F Pojero; F Niceta; P Sammarco; G Corsello; P Garofalo
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.